Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
REPRO-MED Systems (KRMD)
NASDAQ:KRMD
Holding KRMD?
Track your performance easily
Earnings Data
Report Date
Feb 26, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-$0.03Last Year’s EPS
-$0.02Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 13, 2024
|% Change Since: 25.62%
|Next Earnings Date:Feb 26, 2025
Earnings Call Sentiment|Positive
The earnings call reflected a strong performance in revenue growth, improved margins, and a robust pipeline in Novel Therapies. Despite some delays in product submissions, the company showed positive financial results and raised guidance, indicating confidence in future growth. The highlights significantly outweighed the lowlights.Company Guidance
During the KORU Medical Systems Q3 2024 earnings call, the company provided an optimistic update on its financial performance and future outlook. Revenue for the quarter reached $8.2 million, marking a 17% year-over-year increase and continuing a trend of double-digit growth. The gross margin improved by 140 basis points to 63.4%, driven by enhanced profitability in Novel Therapies and operational efficiencies. The company ended the quarter with a cash balance of $8.8 million, indicating a 60% reduction in year-to-date cash usage. KORU raised its full-year revenue guidance to a range between $32.75 million and $33.25 million, representing 15% to 17% growth, and increased its gross margin guidance to 62% to 63%. Operating expenses were revised slightly higher due to strategic investments, but the company remains on track to achieve cash flow breakeven by Q4 2024. Looking ahead, KORU anticipates further growth driven by its Domestic Core and International Core businesses, as well as a robust pipeline in Novel Therapies, with six potential drug launches by 2026.Strong Revenue Growth
Third quarter revenues totaled $8.2 million, representing growth of 17% over the prior year period, marking the third consecutive quarter of double-digit revenue growth.
Improved Gross Margin
Gross profit grew 19% year-over-year and gross margin improved 140 basis points to 63.4%.
Cash Flow and Financial Position
Ending cash balance of $8.8 million was ahead of expectation, with a 60% reduction in year-to-date cash usage compared to the same period of 2023.
International Core Business Growth
International Core business grew 38% year-to-date, driven by consumable growth in new and existing markets.
Novel Therapies Segment Performance
Novel Therapies revenue represented growth of 276% over the prior year, with expectations for consistent revenues moving forward.
Increased Guidance
Revenue growth target increased to a range of $32.75 million to $33.25 million, with raised gross margin guidance to 62% to 63%.
Pipeline and Collaborations
16 current collaborations in Novel Therapies, with 6 expected to launch by 2026, representing a total addressable market of about $2.7 billion.
---
KRMD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
KRMD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 13, 2024 | $3.20 | $3.08 | -3.75% |
| Aug 07, 2024 | $2.13 | $2.48 | +16.43% |
| May 01, 2024 | $2.25 | $2.38 | +5.78% |
| Mar 13, 2024 | $2.12 | $2.19 | +3.30% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does REPRO-MED Systems (KRMD) report earnings?
REPRO-MED Systems (KRMD) is schdueled to report earning on Feb 26, 2025, TBA Not Confirmed.
What is REPRO-MED Systems (KRMD) earnings time?
REPRO-MED Systems (KRMD) earnings time is at Feb 26, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is KRMD EPS forecast?
KRMD EPS forecast for the fiscal quarter 2024 (Q4) is -$0.03.
---